Disability groups hopeful about EU act to make smartphones, apps more accessible
Under the European Accessibility Act (EEA), which was originally proposed in 2019, EU countries must strive to make their services such as websites, emergency numbers, banking, and ticket machines easier to use. Around 100 million people in the EU – roughly one in four adults – have a form of disability.
As of last Saturday, companies and public services in the EU must ensure their products or services comply with the EAA or risk fines. Train ticket machines, for example, will have to come with audio guidance.
Six years since the Commission first announced it was working on the legislation, only about a quarter of relevant EU businesses are fully compliant, Antoine Fobe from the European Blind Union told Euractiv, adding that most will be late.
Fobe welcomed the change, saying it will make a tangible difference for people with disabilities – especially those who are visually impaired – but warned that it must not become 'compliance window dressing.'
Alejandro Moledo, deputy director of the European Disability Forum, echoed the concern. The Commission needs to check that "the law is being applied on the ground," he said.
In 2024, the Commission referred Bulgaria to the EU Court of Justice for failing to transpose the EAA into national law. Ot her countries, including Germany, Croatia, the Netherlands, Sweden, Slovenia, and Greece, face additional procedures for missing parts of the criteria, Moledo said.
At a panel event hosted by AccessibleEU, manufacturers pointed to difficulties in creating a unified accessibility standard for payment systems, especially as many disabled users rely on smartphones and services like Apple Pay.
Moledo added that the law could have gone further. The current scope, he said, is narrower than what the European Disability Forum had campaigned for before 2019.
Meanwhile, the European Parliament's health committee in June backed a report from Left MEP Giorgos Georgiou calling for stronger disability rights protections – including improving access to new technologies. (de, jp)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euractiv
11 hours ago
- Euractiv
Disability groups hopeful about EU act to make smartphones, apps more accessible
Brussels wants ATMs, smartphones, websites and other services to be more accessible, and after years of campaigning, disability groups remain cautiously optimistic that change is on the way. Under the European Accessibility Act (EEA), which was originally proposed in 2019, EU countries must strive to make their services such as websites, emergency numbers, banking, and ticket machines easier to use. Around 100 million people in the EU – roughly one in four adults – have a form of disability. As of last Saturday, companies and public services in the EU must ensure their products or services comply with the EAA or risk fines. Train ticket machines, for example, will have to come with audio guidance. Six years since the Commission first announced it was working on the legislation, only about a quarter of relevant EU businesses are fully compliant, Antoine Fobe from the European Blind Union told Euractiv, adding that most will be late. Fobe welcomed the change, saying it will make a tangible difference for people with disabilities – especially those who are visually impaired – but warned that it must not become 'compliance window dressing.' Alejandro Moledo, deputy director of the European Disability Forum, echoed the concern. The Commission needs to check that "the law is being applied on the ground," he said. In 2024, the Commission referred Bulgaria to the EU Court of Justice for failing to transpose the EAA into national law. Ot her countries, including Germany, Croatia, the Netherlands, Sweden, Slovenia, and Greece, face additional procedures for missing parts of the criteria, Moledo said. At a panel event hosted by AccessibleEU, manufacturers pointed to difficulties in creating a unified accessibility standard for payment systems, especially as many disabled users rely on smartphones and services like Apple Pay. Moledo added that the law could have gone further. The current scope, he said, is narrower than what the European Disability Forum had campaigned for before 2019. Meanwhile, the European Parliament's health committee in June backed a report from Left MEP Giorgos Georgiou calling for stronger disability rights protections – including improving access to new technologies. (de, jp)
Euractiv
13 hours ago
- Euractiv
Denmark introduces mandatory conscription for women amid growing threat from Russia
Denmark is ramping up military spending and begins including women in compulsory military service as of 1 July in a bid to bolster its defence against the growing threat from Russia. All those turning 18 after 1 July 2025 will be eligible for possible conscription into the Danish Armed Forces. Until now, this has been limited to men, although women were allowed to volunteer. In Denmark, a lottery system determines who gets drafted: each eligible conscript draws a number from a tombola. If the number is lower than the required number of conscripts not covered by volunteers, it means putting on a uniform. The country's centrist government, the Greens and most of the conservative opposition agreed on the changes in April last year, today they came into force – coinciding with the day Denmark takes over the rotating EU council presidency. The new rules should help Denmark address "the current security situation", Colonel Kenneth Strøm, head of the conscription programme, told AP. They include an extension of conscription duration from four to eleven months, with plans to train 6,500 conscripts annually from 2033 – a 40% increase on current figures. At the moment, the nation of 6 million has 9,000 professional troops. The new rules also make it easier for individuals with diabetes and ADHD. If need be, the Danish defence minister has the authority to deploy conscripts abroad. Among the Nordic countries, Denmark is the last of the three to include women in the mandatory conscription process. Norway made similar changes in 2013 and Sweden followed suit in 2017. Denmark has been one of the biggest donors of aid to Ukraine, with allocations of 9.5 billion euros – which is around 2.6% of the country's GDP. (vib)
Euractiv
13 hours ago
- Euractiv
Belgian biotech stakeholders urge EU to fast-track innovation and financing reforms
As the European Commission prepares its Biotech Act, Belgium's biotech sector has submitted detailed responses to the Commission's call for evidence, advocating for a bold and comprehensive legislative package. If the EU wants to lead in global biotechnology, the Biotech Act must deliver radical simplification, stronger financial instruments, and smarter regulation, they say. Sharing priorities and concerns, a wide range of Belgian stakeholders, including industry associations, regulators, academic institutions, and patient groups, paint a picture of a country eager to see Europe reclaim its leadership in biotechnology. A turning point for EU biotech Belgium punches above its weight in biotech, home to thriving clusters in Flanders and Wallonia, as well as over 450 innovation-driven biotech entities. But recent trends have raised alarm. Clinical trial authorisations in Belgium dropped by 10% between 2022 and 2023, part of a broader EU decline. 'Over the past five years, 60,000 EU patients missed out on clinical trials,' warned The message from Belgium is clear: without fast, pragmatic reforms, Europe risks falling behind the US and China. 'Regulatory delays, fragmented markets, and lack of capital are costing Europe its biotech edge,' said Biovia, the Flemish health innovation cluster. 'The Biotech Act must turn scientific excellence into global competitiveness.' Streamlining regulation All Belgian contributors emphasise the need to streamline regulatory frameworks, particularly in clinical trials, market access and data governance. called for a reform of the EU Clinical Trial Regulation (CTR) to reduce national divergences, shorten approval timelines, and minimise administrative burdens for modifications during trials. Amgen echoed these concerns, advocating for a centralised EU procedure under EMA oversight, especially for combination products involving medical devices or diagnostics. The Flemish government similarly pushed for harmonised, lean approval procedures aligned across sectors, calling for 'regulatory sandboxes' to support high-risk innovation. The Belgian Federal Agency for Medicines and Health Products (FAMHP) warned of duplicative procedures, inconsistent interpretations between Member States, and a lack of clarity on the regulatory status of advanced therapies. It flagged the need for harmonisation in the handling of genetically modified organisms (GMOs) in clinical trials and import regulations for short-life advanced therapy medicinal products (ATMPs), noting that the current customs procedures are unfit for these innovative medicines. Investing in innovation, not just frameworks Beyond regulation, financing innovation emerged as a central demand. Biovia and VIB both highlighted Europe's chronic funding gap, particularly in growth-stage biotech. 'The EU lags the US by a factor of six to ten in available biotech capital,' Biovia noted, calling for more non-dilutive EU funding, a unified biotech stock exchange, and better incentives for pension funds and long-term investors. VIB proposed a 'EuroTech Stock Exchange' modelled after NASDAQ and urged the Commission to mandate more venture-friendly policies at the European Investment Fund (EIF). 'EIF-backed funds should prioritise excellence, not geographical quotas that distort investments,' it argued. The Flemish government, in turn, advocated for prioritising biotech in the forthcoming European Competitiveness Fund and creating pan-European access to pilot plants and infrastructures, including for SMEs. Digital, data, and AI Belgian stakeholders were aligned in calling for greater digital integration. MSD, and Sanofi stressed the importance of secure, high-quality datasets, interoperable systems, and responsible AI integration. Leveraging the European Health Data Space (EHDS), aligning with the AI Act, and enabling real-world evidence (RWE) use in clinical trials were flagged as top priorities. The FAMHP also called for broadening the focus from AI to include a wider range of digital tools such as modelling, simulation, and 'white-box' computational methods. Meanwhile, Amgen called for a Regulatory Innovation Fund to support digital regulatory sandboxes and keep EMA guidance on biotech manufacturing up to date. Environmental balance A notable concern raised by was the EU's environmental legislation, in particular the Urban Waste Water Treatment Directive (UWWTD). The group urged the Commission to pause its implementation and redesign the directive in line with the 'polluter pays' principle. Currently, only the pharmaceutical and cosmetic industries are expected to foot the bill for micropollutant removal, while industrial chemicals, pesticides, and household products are excluded. 'This undermines both competitiveness and the valorisation of green innovation,' warned. Paediatric oncology In a poignant submission, patient group KickCancer stressed that paediatric cancer research illustrates the untapped promise and systemic failings of the current biotech landscape. The group called for a true single market to support early, multinational paediatric trials, wider access to CAR-T and other ATMPs, and a financing model that combines public and private capital to keep therapies affordable. 'We must build a European model for low-cost, high-impact paediatric cancer treatments,' the group stated. Coordinated ecosystem Belgium's submissions also underscore that biotech policy must move beyond healthcare. The Flemish government and Biovia argued for a full-spectrum approach that includes food, agriculture, industrial biotech, and recycling. Biovia's recent merger of and MEDVIA reflects this shift, positioning itself as a cluster for both human and planetary health. Belgian actors support integrating New Genomic Techniques (NGTs) into climate adaptation policies and promoting sustainable biotech use in agriculture and food. They also called for simplifying Regulation (EC) No 1107/2009 to better accommodate biocontrol products and microbial biostimulants, noting that many promising innovations remain excluded under current EU rules. Belgium's biotech ecosystem speaks with unity on the future of European biotechnology, converging on three pillars: streamline regulation, secure strategic financing, and empower innovation with digital infrastructure. [Edited by Vasiliki Angouridi, Brian Maguire]
